Bellerophon Provides Update on INOpulse Phase 2b Clinical Program for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease Company News
Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial Life Science Investing
BriaCell Initiates Dosing in Phase I/IIa Combination Study with KEYTRUDA® or YERVOY® Biotech Investing
Naturally Splendid Receives Investment Commitment for $2,000,000 from Wahupta Ventures Inc. for Cannabinoid Extraction Facility Cannabis Investing News
Life Science Big News Roundup: Isodiol International Inc. Subsidiary, BSPG Laboratories LTD., Launches API Sales and Marketing Program at CPhI 2018; PreveCeutical Announces LOI to Acquire Penta 5 Health and Wellness Packaging Companies Life Science Investing
Sarepta Announces Agreement with Nationwide Children’s Hospital for Rights to its Gene Therapy Program Pharmaceutical Investing
Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program Pharmaceutical Investing
Calithera Biosciences Announces Clinical Trial Collaboration to Evaluate IBRANCE (palbociclib) and talazoparib in Combination with CB-839 Biotech Investing
